| WST |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$855M vs. cons $842.7M |
MEDIUM |
| WST |
Report |
HVP Components Revenue (Q2 2026) |
BEAT |
pred ~$425M vs. cons $414.4M |
MEDIUM |
| WST |
Report |
Adj. EPS Diluted (Q2 2026) |
BEAT |
pred ~$2.18 vs. cons $2.094 |
MEDIUM |
| WST |
Guide |
Revenue (Q3 2026) |
BETTER |
guide ~$855-875M vs. cons ~$843M |
MEDIUM |
| WST |
Guide |
Revenue (FY 2026) |
BETTER |
guide ~$3,360-3,400M vs. cons $3,331M |
MEDIUM |
| WST |
Guide |
Adj. EPS (FY 2026) |
BETTER |
guide ~$8.75-9.00 vs. cons $8.614 |
MEDIUM |
| WST |
Guide |
HVP organic growth tone (FY 2026) |
BETTER |
low-to-mid teens maintained; Non-GLP-1 tone more confident vs. cons ~10.3% Prop. organic |
MEDIUM |
| WST |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| WST |
Return |
5-day cumulative residual |
+3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — FY estimate revisions pull Q3/Q4 estimates up; limited by high bar and BDX read-through already priced |
MEDIUM |